Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs

Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.

Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.

drug development
Q&A: Epigenetic Therapies for Breast Cancer
Q&A: Epigenetic Therapies for Breast Cancer
Katarina Zimmer | Apr 4, 2019
Breast cancer researcher and oncologist Nancy Davidson discusses what we’ve learned from the first wave of epigenetic trials for breast cancer, and what challenges lie ahead before such therapies reach the clinic.
Miracle Elixirs
Miracle Elixirs
Bob Grant | Apr 1, 2019
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.
FDA Commissioner Scott Gottlieb Announces Resignation
FDA Commissioner Scott Gottlieb Announces Resignation
Jef Akst | Mar 5, 2019
Gottlieb will step down after two years at the helm of the US Food and Drug Administration to spend more time with his family.
Drugs, Developed
Drugs, Developed
Bob Grant | Mar 1, 2019
In an era of instant communication, we must be careful how word of new and untested treatments is shared.
Are We Headed for a New Era of Malaria Drug Resistance?
Are We Headed for a New Era of Malaria Drug Resistance?
Natalie Slivinski | Mar 1, 2019
Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.
Big Pharma Picks up on Medical Marijuana
Big Pharma Picks up on Medical Marijuana
Ashley P. Taylor | Dec 19, 2018
A Novartis subsidiary is partnering with a Canadian cannabis company to sell medical marijuana worldwide.
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
GlaxoSmithKline to Acquire Cancer Biotech TESARO for $5.1 Billion
Carolyn Wilke | Dec 3, 2018
The purchase aims to build GSK’s oncology pipeline.
Parkinson’s Patient Transplanted with Neurons Derived from iPSCs
Parkinson’s Patient Transplanted with Neurons Derived from iPSCs
Ashley P. Taylor | Nov 14, 2018
This is the first time researchers have tested the use of the reprogrammed stem cells in the human brain.
Ebola Clinical Trial to Begin Amid Outbreak in DRC
Ebola Clinical Trial to Begin Amid Outbreak in DRC
Ashley P. Taylor | Nov 12, 2018
The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.